The trading price of Johnson & Johnson (NYSE:JNJ) floating higher at last check on Monday, April 22, closing at $149.12, 0.82% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 19.10. In examining the 52-week price action we see that the stock hit a 52-week high of $175.97 and a 52-week low of $143.13. Over the past month, the stock has lost -4.26% in value.
Johnson & Johnson, whose market valuation is $359.35 billion at the time of this writing. The dividend yield on the company stock is 3.19%, while its Forward Dividend ratio is 4.76. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Johnson & Johnson No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest JNJ has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 3.65, which symbolizes a positive outlook. A quick review shows that JNJ’s price is currently -1.83% off the SMA20 and -4.48% off the SMA50. The RSI metric on the 14-day chart is currently showing 40.74, and weekly volatility stands at 1.82%. When measured over the past 30 days, the indicator reaches 1.38%. Johnson & Johnson (NYSE:JNJ)’s beta value is currently sitting at 0.54, while the Average True Range indicator is currently displaying 2.28.
To see how Johnson & Johnson stock has been performing today in comparison to its peers in the industry, here are the numbers: JNJ stock’s performance was 0.82% at last check in today’s session, and -8.84% in the past year. Johnson & Johnson has a P/E ratio of 19.10.
An evaluation of the daily trading volume of Johnson & Johnson (NYSE:JNJ) indicates that the 3-month average is 7.49 million.
Currently, records show that 2.41 billion of the company’s shares remain outstanding. The insiders hold 0.16% of outstanding shares, whereas institutions hold 71.38%. However, since the stock’s price has seen -4.86% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
